Amyloidosis electrocardiogram: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Amyloidosis}} | {{Amyloidosis}} | ||
{{CMG}}; {{AE}} | {{CMG}} {{shyam}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Electrocardiogram is particularly useful for cardiac amyloidosis. Findings on electrocardiogram include a variety of findings. | |||
==Electrocardiogram== | ==Electrocardiogram== | ||
Electrocardiogram is particularly useful for cardiac amyloidosis. Findings on electrocardiogram include: | |||
*Low voltage QRS complexes<ref name="pmid22058156">{{cite journal| author=Guan J, Mishra S, Falk RH, Liao R| title=Current perspectives on cardiac amyloidosis. | journal=Am J Physiol Heart Circ Physiol | year= 2012 | volume= 302 | issue= 3 | pages= H544-52 | pmid=22058156 | doi=10.1152/ajpheart.00815.2011 | pmc=3353775 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22058156 }} </ref> | |||
*Left ventricular hypertrophy<ref name="pmid25743445">{{cite journal| author=Damy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J| title=Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. | journal=J Cardiovasc Transl Res | year= 2015 | volume= 8 | issue= 2 | pages= 117-27 | pmid=25743445 | doi=10.1007/s12265-015-9613-9 | pmc=4382536 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25743445 }} </ref> | |||
*Right ventricular hypertrophy<ref name="pmid25743445">{{cite journal| author=Damy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J| title=Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. | journal=J Cardiovasc Transl Res | year= 2015 | volume= 8 | issue= 2 | pages= 117-27 | pmid=25743445 | doi=10.1007/s12265-015-9613-9 | pmc=4382536 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25743445 }} </ref> | |||
*Left atrial abnormalities | |||
*Pathological Q waves<ref name="pmid25743445">{{cite journal| author=Damy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J| title=Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. | journal=J Cardiovasc Transl Res | year= 2015 | volume= 8 | issue= 2 | pages= 117-27 | pmid=25743445 | doi=10.1007/s12265-015-9613-9 | pmc=4382536 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25743445 }} </ref> | |||
*Atrioventricular block: | |||
**First-degree AV block | |||
**Second-degree AV block | |||
**Third-degree AV block | |||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 18:58, 2 January 2019
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Amyloidosis electrocardiogram On the Web |
|
American Roentgen Ray Society Images of Amyloidosis electrocardiogram |
|
Risk calculators and risk factors for Amyloidosis electrocardiogram |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief:
Overview
Electrocardiogram is particularly useful for cardiac amyloidosis. Findings on electrocardiogram include a variety of findings.
Electrocardiogram
Electrocardiogram is particularly useful for cardiac amyloidosis. Findings on electrocardiogram include:
- Low voltage QRS complexes[1]
- Left ventricular hypertrophy[2]
- Right ventricular hypertrophy[2]
- Left atrial abnormalities
- Pathological Q waves[2]
- Atrioventricular block:
- First-degree AV block
- Second-degree AV block
- Third-degree AV block
References
- ↑ Guan J, Mishra S, Falk RH, Liao R (2012). "Current perspectives on cardiac amyloidosis". Am J Physiol Heart Circ Physiol. 302 (3): H544–52. doi:10.1152/ajpheart.00815.2011. PMC 3353775. PMID 22058156.
- ↑ 2.0 2.1 2.2 Damy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J (2015). "Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis". J Cardiovasc Transl Res. 8 (2): 117–27. doi:10.1007/s12265-015-9613-9. PMC 4382536. PMID 25743445.